Eden Research (LON:EDEN) Hits New 52-Week Low – Should You Sell?

Shares of Eden Research plc (LON:EDEN) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 1.90 and last traded at GBX 2.12, with a volume of 13468 shares changing hands. The stock had previously closed at GBX 2.10.

Eden Research Stock Up 1.0%

The company has a current ratio of 1.95, a quick ratio of 2.42 and a debt-to-equity ratio of 5.41. The stock has a market capitalization of £17.03 million, a P/E ratio of -4.78 and a beta of 1.61. The firm’s fifty day moving average is GBX 2.41 and its 200-day moving average is GBX 2.94.

Eden Research (LON:EDEN) last released its quarterly earnings results on Wednesday, August 26th. The company reported GBX (0.36) EPS for the quarter. Eden Research had a negative net margin of 50.43% and a negative return on equity of 16.16%. As a group, equities research analysts predict that Eden Research plc will post -66.0000038 earnings per share for the current year.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.